Keywords: copaxone, pushes, teva, fy, profits, up, israeli
Copaxone pushes Teva FY profits up 39.3%
Article | 16 February 2000
Israeli drugmaker Teva says that fourth-quarter 1999 sales, which rose28% to $379.9 million, brought total revenues for last year to $1.28 billion (+15%). Net ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
